Proya donates over 90,000 EU standards-compliant face masks to front line medical staff in China's Hubei


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Proya
Proya donates 90,000 face masks

More than 110,000 face masks, purchased from European countries by cosmetics maker Proya, were delivered to frontline medical staff in China's Hubei province on February 4. Accompanied by Proya executives, the face masks, including some 90,000 European standards-compliant masks (FFP3/FPP2, which outperforms N99/N95 in terms of filtration efficiency) and 20,000 disposable masks, were escorted by local police officers under the supervision of Hubei province government officials, as the delivery destination limits entry of non-locally registered vehicles. To date, Proya executives have successfully delivered 68,000 face masks to the 2nd People's Hospital of Xishui in Huanggang city, and an additional 43,880 masks to the Hubei Charity Federation.

Wuhan, the epicenter of the 2019-nCOV outbreak, was put on lockdown on the eve of the Chinese New Year. On that day, Proya established a special group for epidemic response. With co-founder and CEO Fang Yuyou serving as the general director, the firm also formally set up a RMB15 million (approx. USD2.2 million) charitable public fund to enhance the effort to control and prevent further spreading of the 2019-nCoV virus. Proya has donated 4 million yuan to the cities of Wuhan, Wenzhou and Leqing as well as over 110,000 face masks to designated recipients. The firm will continue to do its utmost to meet domestic demand for supplies and to help prevent and control further spread of the disease.

Purchasing supplies from Europe for designated donations

According to Mr. Fang, their previous donations were mainly in cash. Coinciding with the Chinese New Year, the unexpected 2019-nCoV outbreak caused a severe shortage of medical supplies across China. As a result, Proya focused more on supplies purchases, in addition to cash donations.

Among the more than 110,000 face masks Proya purchased from Europe, 68,000 were donated to the 2nd People's Hospital of Xishui in Huanggang, as the city faced a severity level in terms of the virus outbreak close to that experienced in Wuhan. As of February 3, Huanggang had reported 1,422 confirmed cases, of which 210 took place in Xishui, the second largest populous county in the city.

Purchasing the face masks was a tough task. Immediately after the lockdown in Wuhan, Proya appointed Pan Xiang, director of the firm's European brand agency, to set up purchase teams. Due to tight supplies of medical protective devices in Europe, the purchase teams had to chase supplies in many European countries. The purchase task was even more challenging as Proya had to ensure the purchased items met the donation and use standards at China's domestic hospitals.

Tags : #Proya #Facemask #90000 #Donates #China #Medicircle

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026